156 related articles for article (PubMed ID: 36536564)
1. [Application study of stool-based methylated SDC2 test in the screening of colorectal neoplasms for physical examination population].
Wang L; Huang ZM; Jiang YY; Zhu M; Zhang N; Xiong FB; Zou HZ; Xu XH
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Dec; 56(12):1767-1773. PubMed ID: 36536564
[No Abstract] [Full Text] [Related]
2. Methylation of Septin9, SRSF1, and PAX8 in Early Screening of Colorectal Cancer in the Population Undergoing Physical Examinations.
Li Q; Jiang W; Zhang Y; Yang X; Huang T; Huang Y; Yang S; Wang Q
Clin Lab; 2023 Dec; 69(12):. PubMed ID: 38084698
[TBL] [Abstract][Full Text] [Related]
3. Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical study.
Wang J; Liu S; Wang H; Zheng L; Zhou C; Li G; Huang R; Wang H; Li C; Fan X; Fu X; Wang X; Guo H; Guan J; Sun Y; Song X; Li Z; Mu D; Sun J; Liu X; Qi Y; Niu F; Chen C; Wu X; Wang X; Song X; Zou H
Clin Epigenetics; 2020 Oct; 12(1):162. PubMed ID: 33126908
[TBL] [Abstract][Full Text] [Related]
4. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.
Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK
Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial.
Kim CW; Kim H; Kim HR; Kye BH; Kim HJ; Min BS; Oh TJ; An S; Lee SH
BMC Gastroenterol; 2021 Apr; 21(1):173. PubMed ID: 33858326
[TBL] [Abstract][Full Text] [Related]
6. A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA.
Ma L; Qin G; Gai F; Jiang Y; Huang Z; Yang H; Yao S; Du S; Cao Y
BMC Gastroenterol; 2022 Apr; 22(1):191. PubMed ID: 35436855
[TBL] [Abstract][Full Text] [Related]
7. [Methylated
Kong XH; Zhang Z; Deng DH; Yu ZQ; Zhan K; He XS
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Apr; 26(4):372-379. PubMed ID: 37072315
[No Abstract] [Full Text] [Related]
8. Significance of SDC2 and NDRG4 methylation in stool for colorectal cancer diagnosis.
Long L; Sun Q; Yang F; Zhou H; Wang Y; Xiao C; He Q; Yi B
Clin Biochem; 2024 Feb; 124():110717. PubMed ID: 38224931
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of combined detection of multigene mutation and SDC2/SFRP2 methylation in stool specimens for colorectal cancer early diagnosis.
Lin J; Zhang L; Chen M; Chen J; Wu Y; Wang T; Lu Y; Ba Z; Cheng X; Xu R; Tian T; Sun A; Zhang T; Chen M
Int J Colorectal Dis; 2022 Jun; 37(6):1231-1238. PubMed ID: 35499710
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of quantifying
Oh TJ; Oh HI; Seo YY; Jeong D; Kim C; Kang HW; Han YD; Chung HC; Kim NK; An S
Clin Epigenetics; 2017; 9():126. PubMed ID: 29225717
[TBL] [Abstract][Full Text] [Related]
11. Stool DNA Test of Methylated
Niu F; Wen J; Fu X; Li C; Zhao R; Wu S; Yu H; Liu X; Zhao X; Liu S; Wang X; Wang J; Zou H
Cancer Epidemiol Biomarkers Prev; 2017 Sep; 26(9):1411-1419. PubMed ID: 28619831
[No Abstract] [Full Text] [Related]
12. Combined detection of SDC2/ADHFE1/PPP2R5C methylation in stool DNA for colorectal cancer screening.
Li B; Liu S; Gao Y; Zheng L; Lu Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10241-10253. PubMed ID: 37270460
[TBL] [Abstract][Full Text] [Related]
13. Analysis of
Park YS; Kim DS; Cho SW; Park JW; Jeon SJ; Moon TJ; Kim SH; Son BK; Oh TJ; An S; Kim JH; Chae JD
Gut Liver; 2018 Sep; 12(5):508-515. PubMed ID: 29730903
[TBL] [Abstract][Full Text] [Related]
14. Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancer.
Su WC; Kao WY; Chang TK; Tsai HL; Huang CW; Chen YC; Li CC; Hsieh YC; Yeh HJ; Chang CC; Wang JY
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33393623
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
[No Abstract] [Full Text] [Related]
16. A novel plasma based early colorectal cancer screening assay base on methylated SDC2 and SFRP2.
Zhao G; Ma Y; Li H; Li S; Zhu Y; Liu X; Xiong S; Liu Y; Miao J; Fei S; Zheng M; Zhao X
Clin Chim Acta; 2020 Apr; 503():84-89. PubMed ID: 31962098
[TBL] [Abstract][Full Text] [Related]
17. Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients.
Prince M; Lester L; Chiniwala R; Berger B
World J Gastroenterol; 2017 Jan; 23(3):464-471. PubMed ID: 28210082
[TBL] [Abstract][Full Text] [Related]
18. A systematic evaluation of stool DNA preparation protocols for colorectal cancer screening via analysis of DNA methylation biomarkers.
Jin S; Ye Q; Hong Y; Dai W; Zhang C; Liu W; Guo Y; Zhu D; Zhang Z; Chen S; Wang Y; Li D; Ma W; Yang Z; Li J; Zheng Z; Luan J; Wu X; Jiang F; Xu C; Ding C
Clin Chem Lab Med; 2020 Jul; 59(1):91-99. PubMed ID: 32673280
[TBL] [Abstract][Full Text] [Related]
19. Asia-Pacific Colorectal Screening Score Combined With Stool DNA Test Improves the Detection Rate for Colorectal Advanced Neoplasms.
Xu J; Rong L; Gu F; You P; Ding H; Zhai H; Wang B; Li Y; Ma X; Yin F; Yang L; He Y; Sheng J; Jin P
Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1627-1636.e4. PubMed ID: 36113828
[TBL] [Abstract][Full Text] [Related]
20. Value of faecal exfoliated cells in colorectal tumour screening using SDC2 methylation test.
Liu YM; Peng L; Chen C; Zhou P; Cheng B; Luo Y; Zhou MF; Xuan SX; Lin JD; Yin WG
Ann Med; 2023; 55(2):2261111. PubMed ID: 37783044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]